Hypersensitivity and Autoimmune Disease Flashcards

1
Q

Type I hypersensitivity

A
  • Responsible for immediate hypersensitivity typically to allergens
  • Role of IgE in type I hypersensitivity, especially with regard to activating mast cell degranulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type II hypersensitivity

A
  • Tissue and cellular targeting by the immune system
  • Role of antigen-specific IgG autoantibodies
  • Mechanisms of damage induction
    • Inflammatory and non-inflammatory mechanisms
  • Examples
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type III hypersensitivity

A
  • Tissues targeted by type III hypersensitivity responses
  • Immune complex mediated damage – spontaneity of lesion appearance
  • Examples
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Atopy =

A

predisposition to allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Autoimmune disease =

A

failure or breakdown of immune system that maintains tolerance to self tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Loss of tolerance in autoimmune disease is probably due to

A

abnormal selection or lack of control of self-reactive lymphocytes (B and T-cells).

Damage in different autoimmune diseases may result from different effector mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Autoimmune disease is treated through

A
  • Blanket immunosuppression
    • Side-effects including infection
  • Targeted selective approach – target the aberrant immune activation while leaving the rest of the immune system intact
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Autoimmune disease: the cost to individuals and society

A
  • Estimated that 1 in 20 individuals in the western world suffer an autoimmune syndrome
  • Typically chronic long-term disorders [low mortality but high morbidity]
  • Treatments limited to dealing with the symptoms rather than curing the disease
  • Treatments e.g., steroids carry their own risks
  • Patients require intense, careful management and treatment costs run into billions worldwide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type I hypersensitivity steps

A
  • Exposure to allergen occurs in the mucosal lining
  • Activation of THF stimulation of IgE class switching in B cells.
  • Production of IgE
  • Binding of IgE to FCERI on mast cells
  • Repeated exposure to allergen
  • Activation of mast cell causes release of mediators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes autoimmune disease?

A

No known aetiological agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypersensitivity responses

A
  • Hyper response from the immune system
  • Harmful immune responses that may produce tissue injury and cause serious disease
  • 4 categories: Type I, II, III, IV (V)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

antibody mediated hypersensitivity include

A

Type I, II (V), and III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T cell mediated hypersensitivity include

A

type IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Autoimmune diseases usually fall into hypersensitivity

A

Type II, III, and IV categories depending on the type of damage associated with the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mediators of type I hypersensitivity and types

A

Vasoactive amines, lipid mediators (histamine)

- targets vascular/smooth muscle
- immediate hypersensitivity reaction (minutes after repeat exposure to allergens)

Cytokines

- causes inflammation
- late phase reaction (2-4 hours after repeat exposure to allergens)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

type 1 hypersensitivity can cause

A

Vasodilation
Vascular leak
Broncho-constriction
Inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

mediators of type I hypersensitivity and types

A

Vasoactive amines, lipid mediators (histamine)

- targets vascular/smooth muscle
- immediate hypersensitivity reaction (minutes after repeat exposure to allergens)
- IgE mediated effects

Cytokines

- causes inflammation
- late phase reaction (2-4 hours after repeat exposure to allergens)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

type 1 hypersensitivity can cause

A

Immediate reaction

- Vasodilation,
- Oedema
- Vascular congestion

Late reaction

- Eosinophil
- Neutrophil 
- T cell infiltrates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

type 1 hypersensitivity occurs when

A

IgE attaches to soluble antigen and causes an allergic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

type 2 hypersensitivity occurs when

A

IgG attaches to the cell or matrix antigen and causes:

  • AIHA
  • ATP
  • Rheumatic fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

type 3 hypersensitivity occurs when

A

IgG binds to a soluble antigen causing:

  • SLE
  • Rheumatoid arthritis
22
Q

type 4 hypersensitivity occurs when

A
TH1 or TH2 bind to a soluble antigen causing :
- inflammatory cytokinesis 
- chemokines
- toxins
leading to type 1 diabetes , MS, EA, RA

or CTL can bind to a cell antigen and cause cell death

23
Q

type 5 hypersensitivity affects

A

function rather than causing an inflammatory response.

  • Antibody can stimulate receptor without ligand. eg- antibody can bind to a cell causing hormone release
  • Antibody can inhibit binding of ligand to receptor. eg- antibody could bind to actylcholine receptors and cause muscles to no contract when needed
24
Q

Difference between type 2 and type 3 hypersensitivity is clear through

A

Light microscopy :

  • type 2 is more scattered
  • type 3 is more organised

Immunofluorescence:

  • type 2 is more stringy and covers minority of cell
  • type 3 is more spotty and covers majority of cell

Maybe only type 3 is seen through electron microscopy.

25
Q

Graves disease affects

A

TSH receptor.

Mechanism of disease:
- Antibody-mediated stimulation of TSH receptors

Manifestation:
- Hyperthyroidism

26
Q

Systemic lupus erythematosus

A

Target antigen:
- DNA nucleo-protein

Mechanism of disease:
- Complement, FcR mediated inflammation

Manifestation:
Nephritis, arthritis, vasculitis

27
Q

type 4 hypersensitivity basics

A

Cytokine-mediated inflammation leads to inflammation and then tissue injury

T-cell mediated cytotoxicity causes cellkilling and tissue injury

28
Q

T-cell mediated immunologic disease include:

A
  • Type 1 diabetes
  • Rheumatoid arthritis
  • Multiple sclerosis
29
Q

T-cell mediated immunologic disease:

Type 1 diabetes

A

T cell specificity:
- Islet cell antigens (GAD65, insulin)

Animal models:
- Non Obese Diabetic (NOD) mouse

30
Q

T-cell mediated immunologic disease:

Rheumatoid arthritis

A

T cell specificity:
- Joint synovial antigen (Type 2 collagen)

Animal models:
- Collagen induced arthritis

31
Q

T-cell mediated immunologic disease:

Multiple sclerosis

A

T cell specificity:
- Myelin basic protein MOG PLP

Animal models:
EAE

32
Q

Are some individuals susceptible to developing autoimmune disease because of their genetic background?

Can you simply catch an autoimmune disease? In other words is the environment you inhabit more important for disease susceptibility than your genetic background?

A

In virtually all autoimmune diseases it seems to be a bit of both.

33
Q

Twin concordance studies

If an HLA allele is responsible for an AI then monozygotic twins should

A

both develop it if prone and its incidence in dizygotic twins should be high.

T1D
monozygotic 35-50%
dizygotic 5-6%

HLA alleles are important but not solely responsible - other unknown environmental and genetic factors have a role in T1D

34
Q

Ankylosing spondylitis HLA molecule

A

is B27.

Relative risk is 90-100%

35
Q

Genetics vs. Environment in hypersensitivity

A
  • Genetic background of an individual may pre-dispose them to an autoimmune disease
  • Complex, multi-factorial, and by no means the whole story
    - there are risk factors that are independent of genetic
    background
  • Environmental factors
    - the most likely by far is prior infection
  • Other factors may include drugs, trauma, food
36
Q

Rheumatic fever good evidence of

A

molecular mimicry:

  • Streptococcal A
  • Antibodies bind M protein in 2-3 weeks
  • Antibodies crossreact withcardiac myosin
  • And causes Myocarditis
37
Q

Immunological tolerance =

A

state of indifference or non-reactivity towards a substance that would normally be expected to excite an immunological response

State of unresponsiveness to specific antigen:

  • Antigens can be self or foreign
  • Prevents adaptive responses that are damaging (immune pathology) - B cells and T cells
  • Can be exploited by microbes and tumours

Pregnancy, transplantation, autoimmune disease and cancer

38
Q

immunological tolerance can lead to

A

t cells being autoimmune or productive immunity

39
Q

Systemic autoimmune disease

A

Autoimmune processes diffuse; is spread throughout the body

Affects more than one organ - not necessarily the same ones in different individuals

40
Q

Organ specific autoimmune disease

A

Autoimmune process directed against one organ
Type 1 Diabetes - pancreas
Autoimmune Thyroiditis

41
Q

Systemic lupus erythematosus

A

Relapsing and remitting chronic systemic disease

  • Primarily affects women in 20’s - 60’s
  • male:female ratio 1:10
  • DR2/DR3 HLA risk factor (2-3)
  • C2 or C4 complement deficiency seen in 10% of patients
42
Q

glomerulonephritis

A

Immune complex mediated damage of glomeruli can lead to this disease

43
Q

The lupus erythematosus cell (LE cell) Macrophages engorged with

A

apoptotic neutrophils

44
Q

Type 1 diabetes

A

Diabetes arises from a deficiency or inadequate function of insulin

This leads to glucose metabolism abnormalities

  • Initially ketoacidosis, thirst, excess urine
  • Renal failure, heart disease, blindness, neuropathy
  • Destruction of the insulin-producing b cells of the islets of Langerhans in the pancreas

Main therapy - insulin replacement

45
Q

In type 1 diabetes, Islet damage is mediated mainly by

A

CD4+ Th1 T-cells that are reactive with islet autoantigens

46
Q

In type 1 diabetes, Candidate autoantigens include

A

insulin and glutamic acid decarboxylase (GAD65)

47
Q

In type 1 diabetes, Early stages of disease

A

clears signs of necrosis and lymphocyte infiltration (CD4 and CD8)

Autoantibody in blood with specificity for islet cell antigens and insulin

48
Q

Hypersensitivity responses can be defined as

A

damaging responses produced during normal immune responses

49
Q

Chronic activation can lead to q

A

autoimmune disease – different effector mechanisms influence the disease phenotype

50
Q

Autoimmune disease =

A

a failure or breakdown of immune system that maintains tolerance to self tissues

51
Q

Loss of tolerance is probably due to

A

abnormal selection or lack of control of self-reactive lymphocytes (B and T-cells)